Destina Genomica Slne

Destina Genomica Slne is an SME in Granada, Spain that has taken part in 7 EU-funded projects since 2015, receiving €1.1M in EU funding and leading 1 as coordinator.

EU funding received€1.1M
EU projects7
As coordinator1
Running now2
First EU project2015
Latest project2025
CountrySpain
EU registration (PIC)945104369
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Destina Genomica Slne's own share of each project, not the project's full budget.

  • Horizon 2020€823k · 5 projects
  • Horizon Europe€252k · 2 projects

Projects

7 EU-funded projects, newest first. Destina Genomica Slne led 1 of them as coordinator. Each links to the official record.

  • miRAQELAssociated partner

    Statistical Methods for Accurate Quantification of MicroRNA Expression via Small RNA Sequencing

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • ColoMARKPartner

    Identification and development of novel colorectal cancer biomarkers via state-of-the-art liquid biopsy approaches

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €252ktheir share
  • diaRNAgnosisCoordinator

    A novel platform for the direct profiling of circulating cell-free ribonucleic acids in biofluids

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €212ktheir share
  • ARREST-TBPartner

    Accurate, Rapid, Robust and Economical diagnostic technoliogieS for Tuberculosis

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €418ktheir share
  • HaloPartner

    Development and Application of a New Class of Halogenated Reagents to Commercially Valuable Targets

    Horizon 2020 · 2017–2020 · Project on CORDIS ↗

    €81ktheir share
  • LiqbiopsensAssociated partner

    Reliable Novel Liquid Biopsy technology for early detection of colorectal cancer

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

  • miRNA-DisEASYPartner

    microRNA biomarkers in an innovative biophotonic sensor kit for high-specific diagnosis

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €113ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • alcohols
  • breast cancer
  • colorectal cancer
  • drug discovery
  • drug resistance
  • lung cancer
  • microbiology
  • microscopy
  • nanotechnology
  • nucleic acids
  • oncology
  • pharmaceutical drugs

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime